GALSON STEVEN K received a stock award from BIOCRYST PHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/15/2026ACC: 0000882796-26-000053
Director
Since Sep 2021
+48.83K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
48.83K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+15.29K
Price / share
—
Trade value
—
% of position
122.4%
6/11/2026
12.50K→27.79K
Total
Net shares
+15.29K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/11/2026 | A · Award | +15.29K | — | — | 122.4% | 12.50K | 27.79K |
| Total | +15.29K | $0.00 | ||||||
Derivative Transactions1
Automatic Stock Option Grant
Direct
Converts to
Common Stock
33.54K shares
Shares
+33.54K
Strike price
8.50
Held after
33.54K
Exercisable
—
6/11/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Automatic Stock Option Grant Direct | Common Stock33.54K shares | 6/11/2026 | A · Award | +33.54K | 8.50 | — | 33.54K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned58.37K
Total
58.37K indirect58.37K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 58.37K | Indirect |
| Total | 58.37K | 58.37K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported